<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-028X</journal-id>
<journal-title><![CDATA[Vaccimonitor]]></journal-title>
<abbrev-journal-title><![CDATA[Vaccimonitor]]></abbrev-journal-title>
<issn>1025-028X</issn>
<publisher>
<publisher-name><![CDATA[Finlay Ediciones]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-028X2001000100003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Aplicación de la técnica de inmunoperoxidasa para la titulación de cepas del virus Dengue 1]]></article-title>
<article-title xml:lang="en"><![CDATA[Use of the immunoperoxidase technique for the titration of a Dengue 1 virus strain]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[Alicia]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[Nevis]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morier]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Talavera]]></surname>
<given-names><![CDATA[Arturo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[Ela María]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Instituto Finlay  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Instituto de Medicina Tropical Pedro Kourí  ]]></institution>
<addr-line><![CDATA[Ciudad de La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2001</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2001</year>
</pub-date>
<volume>10</volume>
<numero>1</numero>
<fpage>13</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-028X2001000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-028X2001000100003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-028X2001000100003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[La aplicación de la técnica de inmunoperoxidasa para titular virus Dengue ha permitido eliminar algunas de las desventajas que presenta, para este mismo fin, la técnica de formación de placas en cultivos celulares, catalogada como un método fastidioso debido a los múltiples factores que influyen en la formación de las placas. En la literatura consultada se reporta la disminución del tiempo para la obtención de los resultados como la principal ventaja de la primera, pero no datos sobre su precisión. Teniendo esto en cuenta nos propusimos aplicar dicha técnica para titular virus Dengue 1. Se siguió el Procedimiento descrito para realizar la inmunoperoxidasa modificando el tiempo de fijación de las células infectadas de 5, 7 y 10 días y el bloqueo con TSF-Tween 20- SAB 1% durante una hora. La dilución de trabajo para el suero humano utilizado fue de 1/500 y para el líquido ascítico hiperinmune de ratón, contra Dengue 1 fue de 1/100; para los conjugados peroxidasa anti humano y anti ratón empleados, resultaron útiles diluciones de 1/100 y 1/200 para el primero y 1/500 y 1/1000 para el segundo. Se evidenciaron los focos de infección viral, al 7° y 10° días, pero no al 5º. Los títulos virales obtenidos por dos operadores presentaron un Coeficiente de Variación < 30%. Se seleccionó el 7º día para titular el virus, lográndose reducir el tiempo requerido para obtener los resultados con la técnica de placas. No hubo diferencias significativas entre los títulos virales calculados por ambas técnicas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[The use of the immunoperoxidase technique for the titration of Dengue virus has eliminated some of the disadvantages of plaque assay in cell culture for titration, which is considered a fastidious method due to the number of factors involved in the plaque formation. The time reduction to obtain results, is the principal advantage of the immunoperoxidase technique reported in the literature, but nothing is said about its precision. Our purpose was to test the immunoperoxidase technique to titrate Dengue 1 virus in our laboratory. The procedure described for this technique was followed, modified by the fixation of infected cells after 5, 7, and 10 days of incubation and by blocking with TSF-Tween 20- SBA 1% during one hour. The working dilution for the positive human sera was 1/500 and for the polyclonal ascitic fluid (AF) against Dengue 1 obtained in mice, 1/100. The useful dilutions for the anti human and anti mouse peroxidase conjugates were 1/100 and 1/200 for the first and 1/500 and 1/1000 for the second. In these conditions, it was possible to evidence the characteristic foci produced by Dengue 1 virus and to quantify it on the 7th and 10th days, but not on the 5th. The Variation Coefficient was < 30%. The 7th day was chosen as optimum to titrate the virus, leading us to titration faster than by the plaque method. Significant differences were not found between the viral titres obtained by both techniques.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Dengue]]></kwd>
<kwd lng="es"><![CDATA[inmunoperoxidasa]]></kwd>
<kwd lng="en"><![CDATA[Dengue]]></kwd>
<kwd lng="en"><![CDATA[immunoperoxidasa]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font face="Verdana" size="2"><b><font face="Verdana, Arial, Helvetica, sans-serif">ARTICULOS ORIGINALES</font></b></font></p>     <p align="right">&nbsp;</p>     <p align="right"><strong><font size="4" face="Verdana, Arial, Helvetica, sans-serif">Aplicaci&oacute;n de la t&eacute;cnica de inmunoperoxidasa para la  titulaci&oacute;n de cepas del virus Dengue 1.</font></strong></p>     <p align="right">&nbsp;</p>     <p align="right"><strong><font size="3" face="Verdana, Arial, Helvetica, sans-serif">Use of the immunoperoxidase technique for the titration of a Dengue 1 virus strain.</font><font size="2" face="Verdana, Arial, Helvetica, sans-serif">    <br> </font></strong></p>     <p>&nbsp;</p>     <p><strong><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Alicia Aguilar1, Nevis Amin1, Luis Morier2 , Arturo Talavera1, Ela Mar&iacute;a P&eacute;rez1.</font></strong><font size="2" face="Verdana, Arial, Helvetica, sans-serif">    <br> </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1 Instituto Finlay. Centro de Investigaci&oacute;n Producci&oacute;n de Vacunas y Sueros. Ciudad de La Habana, Cuba.    ]]></body>
<body><![CDATA[<br>   E-mail:<a href="mailto:aaguilar@finlay.edu.cu">aaguilar@finlay.edu.cu    <br> </a></font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2 Instituto de Medicina Tropical &quot;Pedro Kour&iacute;&quot; (IPK). Ciudad de La Habana, Cuba.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>RESUMEN</strong>    <br> </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">La aplicaci&oacute;n de la t&eacute;cnica de inmunoperoxidasa para titular virus Dengue ha permitido eliminar algunas de las      desventajas que presenta, para este mismo fin, la t&eacute;cnica de formaci&oacute;n de placas en cultivos celulares,     catalogada como un m&eacute;todo fastidioso debido a los m&uacute;ltiples factores que influyen en la formaci&oacute;n de las      placas. En la literatura consultada se reporta la disminuci&oacute;n del tiempo para la obtenci&oacute;n de los resultados como      la principal ventaja de la primera, pero no datos sobre su precisi&oacute;n. Teniendo esto en cuenta nos propusimos      aplicar dicha t&eacute;cnica para titular virus Dengue 1. Se sigui&oacute; el Procedimiento descrito para realizar la      inmunoperoxidasa modificando el tiempo de fijaci&oacute;n de las c&eacute;lulas infectadas de 5, 7 y 10 d&iacute;as y el bloqueo con      TSF-Tween 20- SAB 1% durante una hora. La diluci&oacute;n de trabajo para el suero humano utilizado fue de 1/500 y      para el l&iacute;quido asc&iacute;tico hiperinmune de rat&oacute;n, contra Dengue 1 fue de 1/100; para los conjugados peroxidasa      anti humano y anti rat&oacute;n empleados, resultaron &uacute;tiles diluciones de 1/100 y 1/200 para el primero y 1/500 y    <br>   1/1000 para el segundo. Se evidenciaron los focos de infecci&oacute;n viral, al 7&deg; y 10&deg; d&iacute;as, pero no al 5&ordm;. Los t&iacute;tulos      virales obtenidos por dos operadores presentaron un Coeficiente de Variaci&oacute;n &lt; 30%. Se seleccion&oacute; el 7&ordm; d&iacute;a      para titular el virus, logr&aacute;ndose reducir el tiempo requerido para obtener los resultados con la t&eacute;cnica de placas.     No hubo diferencias significativas entre los t&iacute;tulos virales calculados por ambas t&eacute;cnicas.    <br> </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Palabras claves:</strong> Dengue, inmunoperoxidasa.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">  <strong>ABSTRACT</strong></font></p>     ]]></body>
<body><![CDATA[<p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">  The use of the immunoperoxidase technique for the titration of Dengue virus has eliminated some of the disadvantages of    plaque assay in cell culture for titration, which is considered a fastidious method due to the number of factors involved in    the plaque formation. The time reduction to obtain results, is the principal advantage of the immunoperoxidase technique    reported in the literature, but nothing is said about its precision. Our purpose was to test the immunoperoxidase technique    to titrate Dengue 1 virus in our laboratory. The procedure described for this technique was followed, modified by the    fixation of infected cells after 5, 7, and 10 days of incubation and by blocking with TSF-Tween 20- SBA 1% during one    hour. The working dilution for the positive human sera was 1/500 and for the polyclonal ascitic fluid (AF) against Dengue    1 obtained in mice, 1/100. The useful dilutions for the anti human and anti mouse peroxidase conjugates were 1/100 and    <br>   1/200 for the first and 1/500 and 1/1000 for the second. In these conditions, it was possible to evidence the characteristic    foci produced by Dengue 1 virus and to quantify it on the 7th and 10th days, but not on the 5th. The Variation Coefficient    was &lt; 30%. The 7th day was chosen as optimum to titrate the virus, leading us to titration faster than by the plaque    method. Significant differences were not found between the viral titres obtained by both techniques.    <br>   </font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><strong>Keywords:</strong> Dengue, immunoperoxidasa.</font></p> <hr>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">Texto completo en pdf</font></p>     <p><font size="2" face="Verdana, Arial, Helvetica, sans-serif"><B>REFERENCIAS</B> </font></p>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">1. Rigau J, Clark G, Gubler DJ, Reiter P, Sanders EJ, Vorndam V. Dengue and dengue haemorrhagic fever. Lancet 1998; 352:971-977. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">2. Soliman KA, Watts DM, Salib AW, Shehata AED, Arthur RR, Botros BAM. Application of an immunoperoxidase monolayer assay for the detection of arboviral antibodies. J Virol Meth 1997; 65:147-151. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">3. Pupo M, Alvarez M, Soto M, Rodr&iacute;guez H, Rodr&iacute;guez R, D&iacute;az M, Guzm&aacute;n MG. Anticuerpos monoclonales al virus dengue 4: espectro de reactividad a los 4 serotipos del dengue. Rev Cubana Med Trop 2000; 52(2):119-125. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">4. Okuno Y, Fukunaga T, Tadano M, Okamoto Y, Ohnishi T, Takagi M. Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system. Arch Virol 1985; 86:129-135. </font>     <P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">5. Churdboonchart V, Kamsattaya K, Yoksan S, Sinarachatanant P, Bhamarapravati N. An application of peroxidase-antiperoxidase (PAP) staining for detection and localization of dengue-2. I. In an endogenous peroxidase containing cell systems. Southeast Asian J Trop Med Public Health 1984; 15(4):547-553. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">6. Despr&eacute;s Ph, Frenkiel MP, Deubel V. Differences between cell membrane fusion activities of two Dengue type- 1 isolates reflect modifications of viral structure. Virology 1993; 196:209-219. </font>     <!-- ref --><p><font size="2" face="Verdana, Arial, Helvetica, sans-serif">7. Marianneau Ph, Steffan AM, Royer C, Drouet MT, Kirn A, Deubel V. Differing infection patterns of Dengue and Yellow Fever viruses in a human Hepatoma cell line. J Infect Dis 1998; 178:1270-1278. </font><!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">8. Malewicz B, Jenkin H. Development of Dengue virus plaques under serum-free overlay medium. J Clin Microbiol 1979; 9(5):609-614. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">9. Gould EA. Grouth, titration and purification of alphaviruses and flaviviruses. En: Mahy BWJ ed. Virology a practical approach. England: IRL Press; 1985:43-78. </font>     <!-- ref --><P ALIGN="JUSTIFY"><font size="2" face="Verdana, Arial, Helvetica, sans-serif">10. Morens DM, Halstead SB, Repik PM, Ravithat P and Raybourre N. Simplified plaque reduction neutralization assay for dengue virues by semi-micrormethods in BHK 21. Comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiology 1985:250-254.</font>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rigau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gubler]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Reiter]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sanders]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vorndam]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Dengue and dengue haemorrhagic fever]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>352</volume>
<page-range>971-977</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soliman]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Watts]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Salib]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Shehata]]></surname>
<given-names><![CDATA[AED]]></given-names>
</name>
<name>
<surname><![CDATA[Arthur]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Botros]]></surname>
<given-names><![CDATA[BAM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Application of an immunoperoxidase monolayer assay for the detection of arboviral antibodies]]></article-title>
<source><![CDATA[J Virol Meth]]></source>
<year>1997</year>
<volume>65</volume>
<page-range>147-151</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pupo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Anticuerpos monoclonales al virus dengue 4: espectro de reactividad a los 4 serotipos del dengue]]></article-title>
<source><![CDATA[Rev Cubana Med Trop]]></source>
<year>2000</year>
<volume>52</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>119-125</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Okuno]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Fukunaga]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tadano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Okamoto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ohnishi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Takagi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Rapid focus reduction neutralization test of Japanese encephalitis virus in microtiter system]]></article-title>
<source><![CDATA[Arch Virol]]></source>
<year>1985</year>
<volume>86</volume>
<page-range>129-135</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Churdboonchart]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Kamsattaya]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Yoksan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sinarachatanant]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bhamarapravati]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[An application of peroxidase-antiperoxidase (PAP) staining for detection and localization of dengue-2: In an endogenous peroxidase containing cell systems]]></article-title>
<source><![CDATA[Southeast Asian J Trop Med Public Health]]></source>
<year>1984</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>547-553</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Després]]></surname>
<given-names><![CDATA[Ph]]></given-names>
</name>
<name>
<surname><![CDATA[Frenkiel]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Deubel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differences between cell membrane fusion activities of two Dengue type- 1 isolates reflect modifications of viral structure]]></article-title>
<source><![CDATA[Virology]]></source>
<year>1993</year>
<volume>196</volume>
<page-range>209-219</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marianneau]]></surname>
<given-names><![CDATA[Ph]]></given-names>
</name>
<name>
<surname><![CDATA[Steffan]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Royer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Drouet]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Kirn]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Deubel]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Differing infection patterns of Dengue and Yellow Fever viruses in a human Hepatoma cell line]]></article-title>
<source><![CDATA[J Infect Dis]]></source>
<year>1998</year>
<volume>178</volume>
<page-range>1270-1278</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malewicz]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Jenkin]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Development of Dengue virus plaques under serum-free overlay medium]]></article-title>
<source><![CDATA[J Clin Microbiol]]></source>
<year>1979</year>
<volume>9</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>609-614</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gould]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Grouth Titration and purification of alphaviruses and flaviviruses]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Mahy]]></surname>
<given-names><![CDATA[BWJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Virology a practical approach]]></source>
<year>1985</year>
<page-range>43-78</page-range><publisher-name><![CDATA[IRL Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morens]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Halstead]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Repik]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Ravithat]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Raybourre]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Simplified plaque reduction neutralization assay for dengue virues by semi-micrormethods in BHK-21: Comparison of the BHK suspension test with standard plaque reduction neutralization]]></article-title>
<source><![CDATA[J Clin Microbiology]]></source>
<year>1985</year>
<page-range>250-254</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
